French Medical and Biotech Companies Gather in Yokohama to Strengthen Collaboration with Japan
From October 7 to 9, 2026, "BioJapan 2026," one of Asia's largest biotechnology events, will be held at Pacifico Yokohama in Kanagawa Prefecture. It has been announced that French companies and research institutions in the life sciences and healthcare sectors will participate in this event.
The visit of this French delegation to Japan aims to promote technical cooperation and joint research with Japanese companies. France possesses world-class technology in the fields of medicine and biotechnology, and through partnerships with Japanese firms, they aim to develop new medical technologies and services.
At "BioJapan 2026," in addition to the exhibition, there will be "partnering" sessions where companies can engage in direct discussions. It is expected that by combining France's cutting-edge technology with Japan's industrial capabilities, innovation in the healthcare sector will be accelerated.
This initiative represents a significant opportunity for companies in both Japan and France to explore new markets and address societal health challenges. Many stakeholders are looking forward to seeing what new cooperative relationships will emerge at this event, which is garnering global attention.